Stock comparison
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
PIII is larger
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B).
Market value leader
PIII
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B).
Revenue leader
PIII
WGS: $427.54M vs PIII: $1.46B.
Profit leader
WGS
WGS: -$21.00M vs PIII: -$147.95M.
Margin leader
WGS
WGS: -4.9% vs PIII: -10.1% net margin.
| Metric | WGS | PIII |
|---|---|---|
| Market cap | $2.06 B | $2.96 B |
| US-listed rank | #2118 | #1834 |
| Revenue (latest FY) | $427.54M | $1.46B |
| Net income (latest FY) | -$21.00M | -$147.95M |
| Net margin | -4.9% | -10.1% |
| P/E (trailing FY) | - | - |
| SEC filings | 748 | 387 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
P3 Health Partners is 1.4x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $2.06 B).
In their latest fiscal years, GeneDx Holdings Corp. reported $427.54M in revenue while P3 Health Partners reported $1.46B.
Full pages: GeneDx Holdings Corp. and P3 Health Partners, or browse the full rankings.